- Home
- ARQT vs CC Comparison
ARQT vs CC Comparison
Compare ARQT & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- CC
- Stock Information
- Founded
- ARQT 2016
- CC 2014
- Country
- ARQT United States
- CC United States
- Employees
- ARQT N/A
- CC N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- CC Major Chemicals
- Sector
- ARQT Health Care
- CC Industrials
- Exchange
- ARQT Nasdaq
- CC Nasdaq
- Market Cap
- ARQT 2.1B
- CC 2.3B
- IPO Year
- ARQT 2020
- CC N/A
- Fundamental
- Price
- ARQT $20.86
- CC $12.92
- Analyst Decision
- ARQT Strong Buy
- CC Buy
- Analyst Count
- ARQT 7
- CC 8
- Target Price
- ARQT $19.00
- CC $18.00
- AVG Volume (30 Days)
- ARQT 2.0M
- CC 3.0M
- Earning Date
- ARQT 10-28-2025
- CC 11-06-2025
- Dividend Yield
- ARQT N/A
- CC 2.71%
- EPS Growth
- ARQT N/A
- CC N/A
- EPS
- ARQT N/A
- CC N/A
- Revenue
- ARQT $263,464,999.00
- CC $5,850,000,000.00
- Revenue This Year
- ARQT $72.46
- CC $4.91
- Revenue Next Year
- ARQT $31.69
- CC $4.73
- P/E Ratio
- ARQT N/A
- CC N/A
- Revenue Growth
- ARQT 99.50
- CC 0.62
- 52 Week Low
- ARQT $8.03
- CC $9.13
- 52 Week High
- ARQT $21.84
- CC $22.38
- Technical
- Relative Strength Index (RSI)
- ARQT 59.00
- CC 36.42
- Support Level
- ARQT $20.34
- CC $12.53
- Resistance Level
- ARQT $21.84
- CC $14.74
- Average True Range (ATR)
- ARQT 1.09
- CC 0.88
- MACD
- ARQT -0.00
- CC -0.32
- Stochastic Oscillator
- ARQT 65.37
- CC 8.68
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.